Alchemia announces multi-target drug discovery collaboration with AstraZeneca on VAST discovery platform
23 April 2013 | By Alchemia Limited
Alchemia has signed a multi-target, drug discovery collaboration with AstraZeneca...
List view / Grid view
News
Boehringer Ingelheim announces results from one of its HCV Phase III trials
23 April 2013 | By Boehringer Ingelheim
Results from the pivotal Phase III STARTVerso™1 trial...
Novartis once-daily QVA149 shows superior efficacy in reducing exacerbations, improving lung function and quality of life in COPD patients
23 April 2013 | By Novartis
Results from the 64-week SPARK study...
Roche to change Applied Science business structure
23 April 2013 | By Roche
Measures aim to ensure sustained success in a fast-changing market environment...
Amgen welcomes European Commission report on EU biosimilars uptake
22 April 2013 | By Amgen
Amgen welcomes a new report from the European Commission...
Lundbeck introduces Selincro® as the first and only medicine for the reduction of alcohol consumption in alcohol dependent patients
22 April 2013 | By H. Lundbeck A/S
Lundbeck launches Selincro®...
Daiichi Sankyo launches silodosin for the treatment of dysuria in China
22 April 2013 | By Daiichi Sankyo
Daiichi Sankyo announced that its subsidiary, Daiichi Sankyo Pharmaceutical (Beijing) Co., Ltd., has begun marketing silodosin...
Hexyon/Hexacima 6-in-1 pediatric vaccine approved in Europe
22 April 2013 | By Sanofi Pasteur
Hexyon/Hexacima is the only fully liquid, ready-to-use, 6-in-1 pediatric vaccine...
GSK and Theravance announce regulatory submission for ANORO™ ELLIPTA™ in Japan
22 April 2013 | By GlaxoSmithKline
Submission of a regulatory application to the Japanese MHLW...
AstraZeneca and BIND Therapeutics announce worldwide development and commercialisation agreement for cancer nanomedicine
22 April 2013 | By AstraZeneca
“We are excited to grow this collaboration..."
Merck enters agreement with Bristol-Myers Squibb
22 April 2013 | By Merck
Agreement to conduct a Phase II clinical trial evaluating combination of investigational oral candidates MK-5172 and daclatasvir for chronic hepatitis C...
Alcon announces FDA approval of Simbrinza(TM) Suspension
19 April 2013 | By Novartis
A new beta blocker-free, fixed-combination therapy for glaucoma patients...
Baxter achieves its first quarter expectations
19 April 2013 | By Baxter International Inc.
Baxter has reported first quarter financial results in line with the company's previously issued guidance...
Johnson & Johnson announces sale of Elan American Depositary Shares to Elan
19 April 2013 | By Johnson & Johnson
Janssen will receive $11.25 per ADS which will result in an after-tax gain of approximately $213m...
Abbott announces FDA approval and U.S. launch of the TECNIS® Toric intraocular lens for cataract patients
18 April 2013 | By Abbott
TECNIS® Toric 1-Piece intraocular lens has received U.S. FDA approval...
